Showing results (411-420 of 770) with videos related to
Sort By:
Pageof 77
Neurology|November 14, 2008
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisD R Altmann, B Jasperse, F Barkhof, et al.Neurology|August 1, 1997
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trialB W van Oosten, M Lai, S Hodgkinson, et al.Neurology|February 1, 1988
Magnetic resonance imaging of the optic nerve in optic neuritisD H Miller, M R Newton, J C van der Poel, et al.Journal of Neurology|December 4, 2003
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cordJ P Mottershead, K Schmierer, M Clemence, et al.Neurology|January 27, 1998
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritisR Kapoor, D H Miller, S J Jones, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Primary progressive multiple sclerosis diagnostic criteria: a reappraisalX Montalban, J Sastre-Garriga, M Filippi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2000
One year follow up study of primary and transitional progressive multiple sclerosisV L Stevenson, D H Miller, S M Leary, et al.Neurology|January 8, 2010
MRI criteria for MS in patients with clinically isolated syndromesX Montalban, M Tintoré, J Swanton, et al.Neurology|January 5, 2002
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MSP A Brex, P D Molyneux, P Smiddy, et al.Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.Pageof 77